Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Mutation characteristics and prognosis of patients with Fanconi anemia signaling pathway gene mutation myeloproliferative neoplasm].

Zhonghua yi xue za zhi - 24 Mar 2026

Zhang Y H, Teng G S, Hu X, Du C X, Wang Y, Zhang H Q, Li Y Q, Peng L, Duan Y F, Zhao Y H, Shao Z H, Yuan W P, Zhou Y, Bai J

Abstract excerpt

Objective: To analyze the mutation characteristics of myeloproliferative neoplasm (MPN) patients with Fanconi anemia (FA) signaling pathway gene mutation. Methods: MPN patients with FA signaling pathway gene mutations (mutation group) diagnosed in the Second Hospital of Tianjin Medical University from September 2017 to October 2024 were retrospectively included. MPN patients without FA signaling pathway gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fanconi Anemia

Share to Fanconi Anemia Complementation Group D2 Protein

Share to Mutation

Share to Myeloproliferative Disorders

Share to Prognosis

Share to Signal Transduction

Source

Identifiers

PMID: 41856608
DOI: 10.3760/cma.j.cn112137-20251016-02664

Genes

FANCD2
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Mutation characteristics and prognosis of patients with Fanconi anemia signaling pathway gene mutation myeloproliferative neoplasm].PMID 41856608Read ↗

Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia.Semantic proximity Read ↗

[The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].Semantic proximity Read ↗

[Chinese expert consensus on the diagnosis and treatment of Fanconi anemia (version 2022)].Semantic proximity Read ↗

[Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase].Semantic proximity Read ↗

[Analysis of Gene Mutation and Clinical Characteristics Related to Myelodysplastic Syndrome].Semantic proximity Read ↗

[Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm].Semantic proximity Read ↗

[Analysis of Bone Marrow and Peripheral Blood Cytological Characteristics and Prognostic Research in FLT3-ITD mutated Acute Myeloid Leukemia].Semantic proximity Read ↗

Next-generation DNA sequencing identifies mutated FANCD2 Gene as a novel Biomarker for monitoring early disease progression and timely therapeutic interventions in advanced phase Chronic Myeloid Leukemia patientsSemantic proximity Read ↗

Next-Generation DNA Sequencing Identifies Mutated FANCD2 Gene as a Novel Biomarker for Monitoring Early Disease Progression and Timely Therapeutic Interventions in Advanced Phase Chronic Myeloid Leukemia PatientsSemantic proximity Read ↗

[High-Throughput Sequencing Technology for Detection of Gene Mutations in Myeloid Malignancies and Its Clinical Prognostic Significance].Semantic proximity Read ↗

[Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome].Semantic proximity Read ↗

[Analysis of the effect of gene mutations on the efficacy of ruxolitinib in patients with myelofibrosis based on second-generation sequencing technology].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.